Following encouraging clinical results, retatrutide, a new peptide option for treating adult-onset metabolic disorder, has obtained official approval from Great Britain's Drug and Healthcare Agency ( https://rafaeljzgx775535.estate-blog.com/39814807/retatrutide-treatment-peptide-uk-approval-and-launch